Marrone Bio Innovations I...

NASDAQ: MBII · Real-Time Price · USD
0.80
-0.20 (-20.00%)
At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11.1M 10.82M 9.86M 12.6M 11.04M
Cost of Revenue
4.89M 4.36M 3.81M 4.83M 4.07M
Gross Profit
6.21M 6.46M 6.05M 7.77M 6.97M
Operating Income
-7.06M -4.86M -4.41M -2.36M -3.03M
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
-7.61M -5.31M -4.95M -3.03M -3.22M
Net Income
-7.6M -5.31M -4.95M -3.04M -3.26M
Selling & General & Admin
10.07M 8.54M 7.26M 7.29M 7.48M
Research & Development
3.16M 3.53M 3.2M 2.84M 2.51M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
13.23M 12.07M 10.46M 10.12M 9.99M
Interest Expense
551K 450K 372K 355K 393K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
18.12M 16.43M 14.26M 14.95M 14.06M
Income Tax Expense
-11K 4K -3K 3K 41K
Shares Outstanding (Basic)
182.26M 175.57M 176.55M 175.57M 168.94M
Shares Outstanding (Diluted)
182.26M 175.57M 176.55M 175.57M 168.94M
EPS (Basic)
-0.04 -0.03 -0.03 -0.02 -0.02
EPS (Diluted)
-0.04 -0.03 -0.03 -0.02 -0.02
EBITDA
-5.86M -3.68M -3.42M -1.53M -1.74M
EBIT
-7.06M -4.86M -4.58M -2.68M -2.83M
Depreciation & Amortization
1.19M 1.18M 1.15M 1.15M 1.09M